EP3713942
CRYSTALLINE 2-AMINO-2-(HYDROXYMETHYL)PROPANE-1,3-DIOL SALT OF 4-(4-(1-ISOPROPYL-7-OXO-1,4,6,7-TETRAHYDROSPIRO[INDAZOLE-5,4'-PIPERIDINE]-1'-CARBONYL)-6-METHOXYPYRIDIN-2-YL)BENZOIC ACID
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.11.2018EP published:
8.3.2023EP application number:
18811658.6
EPO information:
European Patent Register
Max expiry date:
13.11.2038
Title in English:
CRYSTALLINE 2-AMINO-2-(HYDROXYMETHYL)PROPANE-1,3-DIOL SALT OF 4-(4-(1-ISOPROPYL-7-OXO-1,4,6,7-TETRAHYDROSPIRO[INDAZOLE-5,4'-PIPERIDINE]-1'-CARBONYL)-6-METHOXYPYRIDIN-2-YL)BENZOIC ACIDLanguage of the patent:
English
Timeline
Today
14.11.2018EP application
8.3.2023EP Publication
Owner
Name:
Pfizer Inc.Address:
235 East 42nd Street, New York, NY 10017, US
Inventor
Name:
FERNANDO, DilinieAddress:
Jamaica Plain, Massachusetts 02130, US
Name:
LACASSE, Shawn M.Address:
Griswold, Connecticut 06351, US
Name:
WIGLESWORTH, KristinAddress:
Germantown, Maryland 20874, US
Priority
Number:
201762589256 PDate:
21.11.2017Country:
US
Classification
Categories:
C07D 471/10, C07C 215/10, A61P 1/16, A61P 3/10, A61K 31/438